DA Davidson raised the firm’s price target on Standex (SXI) to $298 from $272 and keeps a Buy rating on the shares after its Q2 earnings beat. The company appears to be plowing ahead on its organic-growth ambitions, with new products accompanied by an improved cycle for existing ones, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SXI:
- Standex International Showcases Growth Inflection in Earnings
- Standex sees Q3 revenue up slightly to moderately from $221.3M in Q2
- Standex reports Q2 adjusted EPS $2.08, consensus $1.99
- SXI Earnings this Week: How Will it Perform?
- Promising Growth Potential for Standex International: Buy Rating Affirmed by Ross Sparenblek